AstraZeneca Pharma posts Q3 net profit at Rs 8.67 crore
The company had posted a net loss of Rs 13.40 crore for the corresponding period of the previous fiscal, AstraZeneca Pharma India said in a filing to BSE.
Drug firm AstraZeneca Pharma India on Saturday reported a standalone net profit of Rs 8.67 crore for the third quarter (Q3) ended December 31.
The company had posted a net loss of Rs 13.40 crore for the corresponding period of the previous fiscal, AstraZeneca Pharma India said in a filing to BSE.
Standalone total income of the company stood at Rs 144.58 crore for the quarter as compared to Rs 108.20 crore for the year ago period.
In a separate filing, AstraZeneca Pharma India said its board has approved the reappointment of Sanjay Murdeshwar as Managing Director of the company for a period of three years, to be effective from May 2, 2016.
"The board noted the resignation of Justin Ooi as Director of the company, effective January 11, 2016," it added.
On Friday, the stock of AstraZeneca Pharma India closed up 1.13% or Rs 12.95 at Rs 1,162.60 on the BSE.